医渡科技有限公司(02158)于2026年4月9日发布2026年3月股份变动月报表，报告期为截至2026年3月31日的一个月。
本月公司法定/注册股本保持不变，维持2,500,000,000股普通股的注册数额，面值为每股USD 0.00002，总注册股本USD 50,000。
期末公司已发行股份(不含库存股)为1,019,808,585股，相较于月初的1,049,119,365股减少29,310,780股；库存股数量从23,531,300股增至52,906,100股，合并计算后，公司本月底已发行股份总数为1,072,714,685股，较月初增加64,020股。
本月公司在多个股份回购交易日共购回29,374,800股，购回价格区间约为每股HKD 5.47至HKD 5.93，相关股份均被持作库存股。同时，公司有部分期权行使，共发行64,020股新股，筹资金额为HKD 8,962.80。此外，公司修订后的首次公开发售后股份奖励计划3月内未发行新股，仍保留16,480,050股可发行额度。
公司声明遵守香港联交所《上市规则》及相关法律法规，所有本月内股份的发行与回购均获得董事会批准。截至报告期末，公司确认维持了足够的公众持股量。公告由董事宫盈盈签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.